Boditech Med Inc. (KOSDAQ:206640)
9,750.00
+50.00 (0.52%)
Oct 2, 2026, 3:30 PM KST
Boditech Med Market Cap
Boditech Med has a market cap or net worth of 211.65 billion as of October 2, 2026. Its market cap has decreased by -31.24% in one year.
Market Cap
211.65B
Enterprise Value
190.70B
Revenue
174.78B
Ranking
n/a
PE Ratio
8.13
Stock Price
9,750.00
ChartMarket Cap Chart
Since September 1, 2015, Boditech Med's market cap has increased from 28.15B to 211.65B, an increase of 651.82%. That is a compound annual growth rate of 19.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 211.65B | -25.94% |
| Dec 30, 2025 | 285.80B | -22.50% |
| Dec 30, 2024 | 368.76B | -18.12% |
| Dec 28, 2023 | 450.36B | 100.01% |
| Dec 29, 2022 | 225.17B | -41.09% |
| Dec 30, 2021 | 382.21B | -29.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samyang Biopharm | 365.84B |
| Curexo | 356.48B |
| Sky Labs | 350.85B |
| ToolGen | 326.52B |
| Value Added Technology | 265.15B |
| Vieworks | 242.24B |
| Bio Plus | 229.85B |
| JETEMA, | 222.98B |